CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
The Influence of Peripheral Arterial Disease on Outcomes
A Pooled Analysis of Mortality in Eight Large Randomized Percutaneous Coronary Intervention Trials
Jacqueline Saw, MD, FRCPC*,
Deepak L. Bhatt, MD, FACC ,*,
David J. Moliterno, MD, FACC ,
Sorin J. Brener, MD, FACC,
Steven R. Steinhubl, MD, FACC,
A. Michael Lincoff, MD, FACC,
James E. Tcheng, MD, FACC ,
Robert A. Harrington, MD, FACC,
Maarten Simoons, MD, FACC||,
TingFei Hu, MS,
Mobeen A. Sheikh, MD,
Dean J. Kereiakes, MD, FACC¶ and
Eric J. Topol, MD, FACC
* Department of Medicine, Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Department of Cardiovascular Medicine, the Cleveland Clinic Foundation, Cleveland, Ohio
Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky
Division of Cardiology, Duke University Medical Center, Durham, North Carolina
|| Department of Cardiology, Erasmus University, Rotterdam, the Netherlands
¶ Lindner Center and the Ohio Heart and Vascular Center at the Christ Hospital, Cincinnati, Ohio
Manuscript received October 15, 2005;
revised manuscript received February 27, 2006,
accepted March 21, 2006.
* Reprint requests and correspondence: Dr. Deepak L. Bhatt, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F25, Cleveland, Ohio 44195 (Email: bhattd{at}ccf.org).
OBJECTIVES: We aimed to evaluate clinical outcomes among peripheral arterial disease (PAD) patients following percutaneous coronary intervention (PCI).
BACKGROUND: A significant proportion of patients with coronary artery disease undergoing PCI have concomitant PAD, which may be associated with worse outcomes.
METHODS: We performed a pooled analysis of 8 randomized PCI trials. We included multicenter PCI trials that compared antiplatelet therapies (EPIC, EPILOG, EPISTENT, RAPPORT, CAPTURE, IMPACT-II, TARGET, and CREDO) and had baseline PAD status recorded. Multivariable analyses were performed with stepwise logistic regression for 7- and 30-day outcomes and Cox regression for 6-month and 1-year events.
RESULTS: In our pooled analysis of 19,867 patients undergoing PCI, 1,602 (8.1%) were previously diagnosed with PAD. Patients with PAD had higher incidences of 7-day death (1.0% vs. 0.4%; p < 0.001) or myocardial infarction (MI) (6.8% vs. 5.6%; p = 0.047), 30-day death (1.7% vs. 0.7%; p < 0.001) or MI (7.4% vs. 6.1%; p = 0.05), 6-month death (4.2% vs. 1.5%; p < 0.001) or MI (9.1%, vs. 7.7%; p = 0.048), and 1-year death (5.0% vs. 2.1%; p < 0.001). There was a trend toward higher major bleeding risk with PAD (4.8% vs. 3.9%; p = 0.06). With multivariable analyses, PAD remains a significant predictor of mortality at 30 days (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.03 to 2.70; p = 0.039), 6 months (HR 1.76, 95% CI 1.31 to 2.37; p < 0.001), and 1 year (HR 1.46, 95% CI 1.08 to 1.96; p = 0.013).
CONCLUSIONS: The presence of PAD is associated with higher rates of post-PCI death and MI, and is an independent predictor of short- and long-term mortality.
|
Abbreviations and Acronyms
| | CAD = coronary artery disease | | CI = confidence interval | | GPIIb/IIIa = glycoprotein IIb/IIIa | | HR = hazard ratio | | MI = myocardial infarction | | OR = odds ratio | | PAD = peripheral arterial disease | | PCI = percutaneous coronary intervention | | TVR = target vessel revascularization |
|
This article has been cited by other articles:
|
|
|
|
 
Endorsed by: the European Stroke Organisation (ESO, Authors/Task Force Members, M. Tendera, V. Aboyans, M.-L. Bartelink, I. Baumgartner, D. Clement, J.-P. Collet, A. Cremonesi, M. De Carlo, et al.
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
Eur. Heart J.,
November 2, 2011;
32(22):
2851 - 2906.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. O. Badheka, A. D. Rathod, A. S. Bharadwaj, S. Bhat, M. A. Kizilbash, V. Veeranna, V. Pidlaon, S. Jacob, and L. Afonso
Outcomes and Risk Prediction Model for Peripheral Arterial Disease in Patients with Stable Coronary Artery Disease
Angiology,
August 1, 2011;
62(6):
473 - 479.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. W. Olin, D. E. Allie, M. Belkin, R. O. Bonow, D. E. Casey Jr, M. A. Creager, T. C. Gerber, A. T. Hirsch, M. R. Jaff, J. A. Kaufman, et al.
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease) Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition Endorsed by the American Academy of Podiatric Practice Management
J. Am. Coll. Cardiol.,
December 14, 2010;
56(25):
2147 - 2181.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Olin, D. E. Allie, M. Belkin, R. O. Bonow, D. E. Casey Jr, M. A. Creager, T. C. Gerber, A. T. Hirsch, M. R. Jaff, J. A. Kaufman, et al.
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)
Circulation,
December 14, 2010;
122(24):
2583 - 2618.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Olin, D. E. Allie, M. Belkin, R. O. Bonow, D. E. Casey Jr, M. A. Creager, T. C. Gerber, A. T. Hirsch, M. R. Jaff, J. A. Kaufman, et al.
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease
Vascular Medicine,
December 1, 2010;
15(6):
481 - 512.
[PDF]
|
|
|
|
|
|
|
C. S. Fox, J. M. Massaro, C. L. Schlett, S. J. Lehman, J. B. Meigs, C. J. O'Donnell, U. Hoffmann, and J. M. Murabito
Periaortic Fat Deposition Is Associated With Peripheral Arterial Disease: The Framingham Heart Study
Circ Cardiovasc Imaging,
September 1, 2010;
3(5):
515 - 519.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Cassar, D. Poldermans, C. S. Rihal, and B. J. Gersh
The management of combined coronary artery disease and peripheral vascular disease
Eur. Heart J.,
July 1, 2010;
31(13):
1565 - 1572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Inglis, J. J. V. McMurray, M. Bohm, M. Schaufelberger, D. J. van Veldhuisen, M. Lindberg, P. Dunselman, A. Hjalmarson, J. Kjekshus, F. Waagstein, et al.
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)
Eur J Heart Fail,
July 1, 2010;
12(7):
698 - 705.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. van Hattum, A. Algra, J. A. Lawson, B. C. Eikelboom, F. L. Moll, and M. J.D. Tangelder
Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
Circulation,
October 20, 2009;
120(16):
1569 - 1576.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Berger, J. L. Petersen, and D. L. Brown
Vascular Disease Burden and In-Hospital Outcomes Among Patients Undergoing Percutaneous Coronary Intervention in New York State
Circ Cardiovasc Interv,
August 1, 2009;
2(4):
317 - 322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Bhatt, E. D. Peterson, R. A. Harrington, F.-S. Ou, C. P. Cannon, C. M. Gibson, N. S. Kleiman, R. G. Brindis, W. F. Peacock, S. J. Brener, et al.
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes
Eur. Heart J.,
May 2, 2009;
30(10):
1195 - 1202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Kertai
Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery: A Core Review
Anesth. Analg.,
March 1, 2008;
106(3):
751 - 758.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Dauerman, R. J. Applegate, and D. J. Cohen
Vascular Closure Devices: The Second Decade
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
1617 - 1626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
270 - 285.
[Full Text]
[PDF]
|
|
|
|
